OBJECTIVE: To determine the role of polymorphisms in the genes for b b3-adrenergic receptor (b b3-AR) and in uncoupling proteins 1 and 2 (UCP-1, UCP-2) in obesity. DESIGN: Association study with three polymorphisms and obesity. SUBJECTS: Two hundred and thirty-six morbidly obese patients who underwent gastric banding surgery, 381 patients from the medical clinic and 198 healthy blood donors. MEASUREMENTS: The frequencies of the W64R in b b3-AR, the À3826A?G in UCP-1 and the 45 bp insertion in the 3 H untranslated region of exon 8 in UCP-2 polymorphisms were determined. RESULTS: There were no signi®cant differences in the frequencies of the b b3-AR and UCP-1 polymorphisms between obese (body mass index, BMI b 30 kgam 2 ) and lean subjects. Lean, but not obese, carriers of the R allele of b b3-AR had a signi®cantly higher BMI. The mean age of obese subjects (excluding diabetics) who were carriers of the G allele of the UCP-1 polymorphism, 36 y, was signi®cantly younger than wild-type, 40 y (P 0.007). This effect was not seen in lean subjects. The effect of the G allele on the mean age of obese subjects was more apparent in subjects who were also carriers of the R allele of the b b3-AR polymorphism. The frequency of the ins allele of UCP-2 was signi®cantly higher in obese subjects, 0.31, than in lean, 0.24 (P 0.002) and carriers of the ins allele had a signi®cantly higher BMI, 38 vs 35 (P 0.005). There was no association between any of the polymorphisms and type II diabetes. CONCLUSION: In a German population, there was no association between the W64R in b b3-AR or the À3826A?G in UCP-1 polymorphisms and obesity. However, they act synergistically to accelerate the development of obesity. The 45 bp insertion in the 3 H untranslated region of exon 8 in UCP-2 polymorphism is associated with obesity.
Introduction
The risk of becoming obese has a strong genetic component. 1 Since single gene defects such as those in the leptin gene are very rare, 2 it is likely that a combination of polymorphisms in one or more candidate genes may contribute to the development of most cases of obesity. Reduced basal metabolic rate (BMR) is one of the factors associated with weight gain in humans 3 and, since it is in part genetically determined, 4 variation in genes involved in determining BMR may contribute to the genetic basis of obesity.
One such gene is that for the b3-adrenergic receptor. A variant, W64R, in the human b3-adrenergic receptor gene has been associated with obesity. However this association is a matter of some controversy. In a recent review article, 5 Strosberg identi®ed some 15 studies in which an association was found and eight studies in which no association was found. In a recent large population-based study of 1259 randomly chosen Germans, no association was found between the W64R polymorphism and obesity. 6 In a metaanalysis of 31 studies, Fujisawa et al 7 concluded that carriers of the R allele may have an average increase of BMI of 0.3 kgam 2 compared with normal homozygous subjects. Moreover, the polymorphism has been associated with low BMR and a greater tendency to gain weight in a number of studies and thus may contribute to an increase in body mass index (BMI) in subjects pre-disposed to obesity through lifestyle or other genetic factors. 8 ± 10 Uncoupling proteins (UCP) are a family of proteins whose function is to uncouple oxidative phosphorylation of ADP to ATP leading to the generation of heat.
11 UCP-1 is expressed in brown adipose tissue, 12 UCP-2 in most tissues including white adipose tissue and UCP-3 in skeletal muscle. 13, 14 The À3826A?G polymorphism in UCP-1 has been associated in some, but not all studies, with a tendency to weight gain and increased BMI. 15 ± 19 Recent studies have suggested an additive effect between the W64R polymorphism and the À3826A?G polymorphism in UCP-1. 15 ± 19 Linkage has been reported between markers close to the UCP-2 gene and obesity, 13 with resting metabolic rate in French Canadians 20 and with a prediabetic phenotype in Pima Indians. 21 Two polymorphisms have been reported in the human UCP-2 gene, an ala?val substitution in exon 4 and a 45 bp insertion in the 3 H untranslated region of exon 8 (ins allele), which in some populations have been associated with resting metabolic rate and obesity. 22 ± 27 In this study we report on the incidence of these three polymorphisms and their interaction in ethnic Germans, with a special emphasis on those with morbid obesity.
Materials and methods

Study subjects
Subjects, ethnic Germans, were recruited from three sources: (1) 236 morbid obese patients undergoing gastric banding surgery at the Evangelisches Krankenhaus, Dinslaken, 35 of whom had type II diabetes; (2) 381 patients from the Medical Clinic of the Universita Èts-Krankenhaus, Eppendorf, Hamburg; these patients form a heterogeneous group including outpatients attending the lipid and diabetes outpatient clinics and inpatients; and (3) 198 blood donors from the Blood Transfusion Service of the Universita Èts-Krankenhaus, Eppendorf, Hamburg, who served as normal controls. Patients gave informed consent and the study was approved by the Ethics Commission of the A È rztekammer Hamburg. The clinical details of the subjects are given in Table 1 . For ethical reasons the blood donors had to remain anonymous and we were therefore unable to obtain their BMI; instead serum leptin levels were determined as an indicator of the degree of obesity. As expected they were signi®cantly lower than those that were measured in obese subjects.
DNA Analysis
DNA was extracted from the buffy coat obtained from 10 ml EDTA blood using standard methods. The W64R genotype was determined as described by Gagnon et al, 28 the UCP-1 polymorphism as described by Valve et al 16 and the 45 bp insertion polymorphism of UCP-2 as described by Walder et al. 23 
Assay of plasma leptin
Plasma leptin levels were determined using the Quantikine TM Human leptin immunoassay manufactured by R&D Systems Inc. of Minneapolis, USA.
Statistical analysis
Values are given as means with standard deviations. Statistical analysis was performed using Student's unpaired t-test, ANOVA and w 2 test on Statistica software. A P-value of 0.05 or less was considered signi®cant. Relative risk and odds ratios were calculated as described by Large et al. 
Results
The frequencies of the W64R in b3-adrenergic receptor (b3-AR), the À3826A?G in UCP-1 and the 45 bp insertion in the 3 H untranslated region of exon 8 in UCP-2 polymorphisms in each subject group according to sex are given in Table 1 . There were no signi®cant differences in the allele frequencies of the b3-AR and UCP-1 polymorphisms between the groups. Morbid obese patients of both sexes showed an increase in the frequency of the ins allele of the UCP-2 polymorphism over blood donors, which in the case of males was statistically signi®cant, P 0.002. Combining the sexes, when the morbid obese patients were divided into those over and those under 40 y of age, then the frequency of the ins allele was signi®-cantly higher amongst the older patients, 0.38 vs 0.27, P 0.01 (Table 2) . Morbid obese patients homozygous for the ins allele were signi®cantly older (41AE 8.0, n 22) than deladel homozygotes (37AE 8.31, n 112), P 0.026 ( Figure 1 ) with heterozygotes being intermediate (39AE 9.76, n 101).
As we were unable to obtain the BMI of the blood donors, to further investigate the association between these polymorphisms and obesity we recruited a heterogeneous group of patients from the Medical Clinic, University Hospital, Hamburg. Since the W64R in b3-AR has been associated with type 2 diabetes and since there have been reports of genetic linkage between markers in the vicinity of the UCP-2 gene and a prediabetic phenotype, 13, 21 a number of patients with type 2 diabetes were included. The subjects were divided into those with and without type 2 diabetes, irrespective of their degree of obesity. For each of the polymorphisms there was an increased frequency in the rarer allele in subjects with type 2 diabetes but in no case was this statistically signi®cant ( Table 3) .
The subject groups were combined and then divided into obese, with a BMI of 30 or more, and lean, with a BMI of less than 30. The blood donors were included amongst the lean controls. The frequencies of the polymorphisms in the obese and lean groups were compared ( Table 4 ). The allele frequencies for each of the polymorphisms were in Hardy ± Weinberg equilibrium. There was no statistically signi®cant differences in the allele frequencies of W64R in b3-AR or the À3826A?G in UCP-1 between obese and lean subjects. In the case of the UCP-2 polymorphism there was a statistically signi®cant association with obesity, the frequency of the ins allele being higher in obese subjects than lean, 0.31 vs 0.22, P 0.002. The relative risk for obesity for insains homozygotes was 2.1 with an odds ratio of 2.2 and for carriers of the ins allele the relative risk was 1.2 and the odds ratio 1.4. Excluding the blood donors from the lean group did not affect this ®nding; for the obese subjects the ins allele frequency was 0.31 and for the lean it was 0.24, P 0.004. When the obese and lean groups (excluding blood donors) were further divided into those aged 40 and over and those less than 40 and the allele frequencies determined, a similar result was obtained to that found for the morbid obese patients. The frequency of the ins allele (0.36) was signi®cantly higher amongst the older obese subjects than in younger ones (0.27), P 0.02. Although the older lean subjects had a higher frequency of the ins allele, 0.25 vs 0.18, this was not statistically signi®cant, P 0.08. The mean BMI for each genotype is presented in Table 5 . Since the subjects formed a heterogeneous group, including patients with dyslipidemia and type 2 diabetes, which are associated with an increase in BMI, we performed an ANOVA with the polymorphism as independent variable, BMI as dependent variable and with sex, age, type 2 diabetes, serum total cholesterol and triglycerides as co-variants. Only the UCP-2 polymorphism had a signi®cant affect, P 0.005. Young (`40 y of age) lean patients who were carriers of the R allele of the b3-AR polymorphism had a signi®cantly higher BMI than older lean patients, 26(AE 2.2) vs 23( AE 2.4), P 0.02. This association was not seen in the obese patients.
Obese subjects (excluding diabetics) who were carriers of the G allele of the À3826A?G UCP-1 were signi®cantly younger (AA 40, AGaGG 36, P 0.005, Figure 2 ), an effect not seen in lean subjects (AA 50, AGaGG 51, P 0.68). This effect was stronger in obese men (AA 46 AE 11.4, AG 37 AE 5.5, GG 37 AE 15.1, P 0.003) than women (AA 38 AE 10.2, 36 AE 7.9, GG 36 AE 10.8, P 0.23). It has been reported that the W64R b3-AR and the À3826A?G UCP-1 polymorphisms may act synergistically, 15 ± 19 therefore obese patients were divided into carriers and non-carriers of the R allele of the b3-AR W64R polymorphism. The effect of the UCP-1 polymorphism on the age of obese patients was much greater in the presence of the R allele. In the absence of the R allele, the mean age of AA homozygotes was 39, n 102 and G carriers, 37, n 87 (P 0.12), whereas in the presence of the R allele, the mean age of AA homozygotes was 45, n 17 and G carriers, 33, n 13, P 0.006 (Figure 2 ).
Discussion
The overall frequency of the W64R polymorphism in the b3-AR amongst the 780 subjects typed here, 0.07 (WW 85.6%, WR 13.8%, RR 0.5%) was the same as that obtained from a population-based survey of 1259 Germans (WW 88.3%, WR 10.8%, RR 0.8%). 6 Consistent with this study, we also found no association with either obesity or type 2 diabetes. In the group of non-obese subjects who were younger than 40 there was a small, but statistically signi®cant, association between carriers of the R allele and higher BMI.
Given that any affect of the polymorphism on BMI is probably very slight, in the order of 0.3 kgam 2 , 7 it is in this sub-group of patients that it would be most apparent, as such a modest effect on BMI would probably not be visible within a morbidly obese population.
We observed no association between the À3826A?G UCP-1 polymorphism and obesity or BMI. This is consistent with the ®ndings reported by other groups. 15, 30 Obese subjects who were carriers of the G allele were signi®cantly younger. Oppert et al 30 have reported that carriers of the G allele show an increase tendency to gain weight. That obese carriers of the G allele are younger is not inconsistent with these ®ndings since an increased tendency for weight gain would result in an accelerated development of obesity. Obese subjects who were carriers of the G allele who were also carriers of the R allele of the b3-AR polymorphism were signi®cantly younger than those who were not. A synergistic effect of the two polymorphisms has been reported by a number of groups. 15 ± 19 In this study we report on a signi®cant association of the 45 bp insertion in the 3 H untranslated region of exon 8 polymorphism in UCP-2 with obesity, particularly amongst older patients. This polymorphism has been the subject of four recent reports with con¯icting ®ndings. 23,25 ± 27 The frequency of the ins allele in 483 French morbid obese with a mean age of 48, 0.25, was not signi®cantly increased over 113 normal weight control subjects, 0.23. 27 The ins allele frequency of 0.29 did not differ between 68 obese and 104 normal weight German children and there was no association with BMI. 26 In contrast in a cross-sectional survey of 453 South Indian subjects with a mean age of 45 the frequency of the ins allele was 0.19 and there was a signi®cant association between the ins allele and increased BMI in women but not in men. 25 This association was more signi®cant, P 0.0001 vs 0.015 in an additional group of 143 South Indians, both men and women, who were parents of a group of NIDDM probands with mean ages of 68 and 58, respectively. The frequency of the ins allele in 780 full-blooded Pima Indians was 0.41 and there was no association with obesity. 23 However, when the 139 subjects over 45 y of age were analyzed separately there was a signi®cant association between the ins allele and increased BMI. Taken together these data suggest that the association of the polymorphism on BMI and obesity is probably a modest one which requires a number of years to manifest itself. This is consistent with the suggestion, made by Cassel et al, 25 that the polymorphism plays a role in the susceptibility to weight gain and for a role in affecting the metabolic rate suggested by Walder et al. 23 In the French study, however, there was no association between the polymorphism and metabolic data and tendency to weight gain in morbidly obese patients who were heterozygous for the polymorphism, no insains homozygotes were present in the French population. 27 Although linkage has been reported between markers close to the UCP-2 gene and diabetes 13 and to a pre-diabetic phenotype in Pima Indians, 21 we found no association between the polymorphism and diabetes. This lack of association with type 2 diabetes is consistent with the reports of Cassell et al, 25 Walder et al 23 and Otabe et al, 27 none of whom found an association between this polymorphism and diabetes. In addition, no association could be found between a second polymorphism in UCP-2, A55V, and diabetes. 22 It would seem improbable that variation in the UCP-2 gene plays an important role in the development of type 2 diabetes.
In conclusion, in this study we show that, although there was no direct association between the W64R in b3-AR and the À3826A?G in UCP-1 polymorphisms and obesity, carriers of the polymorphism tended to develop obesity at a younger age, and the two polymorphisms act synergistically. We ®nd an association between the 45 bp insertion in the 3 H untranslated region of exon 8 polymorphism in UCP-2 with obesity and BMI, especially in older obese subjects.
